Previous studies have demonstrated that the co-administration of cannabinoids augments the pain-relieving effects of opioids, even when administered at subtherapeutic doses.
Topic: CBD
Forty-seven percent of respondents reported having authorized cannabis-based therapies to their pediatric patients.
“This novel study can catalyze the use of CBD as an alternative analgesic to opioids for acute inflammatory pain conditions, which could ultimately help to address the opioid epidemic.”
“Ratings were higher for the broad spectrum as compared to the isolate product, which is consistent with prior data suggesting that cannabinoids can work synergistically to maximize benefits.”
Patients using CBD for pain relief were most likely to either reduce or eliminate their use of other medications.
Brazilian investigators reviewed 59 studies, including 23 clinical trials, assessing the cognitive safety of CBD.
The daily ingestion of CBD leads to significantly improved perceived sleep quality.
“CBD may serve as a useful adjunct for some children with CP, especially those with worse disease severity,” the study’s authors concluded.